• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reduction of the turn-around time for the measurement of rivaroxaban and apixaban: Assessment of the performance of a rapid centrifugation method.

作者信息

Dincq A-S, Lessire S, Pirard G, Siriez R, Guldenpfennig M, Baudar J, Favresse J, Douxfils J, Mullier F

机构信息

Department of Anestesiology, CHU UCL Namur, Namur Thrombosis and Hemostasis Center, Université catholique de Louvain, Yvoir, Belgium.

Department of Pharmacy, Namur Research Institute for LIfe Sciences, Namur Thrombosis and Hemostasis Center, University of Namur, Namur, Belgium.

出版信息

Int J Lab Hematol. 2018 Dec;40(6):e105-e108. doi: 10.1111/ijlh.12870. Epub 2018 Jun 19.

DOI:10.1111/ijlh.12870
PMID:29920946
Abstract
摘要

相似文献

1
Reduction of the turn-around time for the measurement of rivaroxaban and apixaban: Assessment of the performance of a rapid centrifugation method.缩短利伐沙班和阿哌沙班检测周转时间：快速离心法性能评估
Int J Lab Hematol. 2018 Dec;40(6):e105-e108. doi: 10.1111/ijlh.12870. Epub 2018 Jun 19.
2
Measurement of dabigatran, rivaroxaban and apixaban in samples of plasma, serum and urine, under real life conditions. An international study.在实际生活条件下，对血浆、血清和尿液样本中的达比加群、利伐沙班和阿哌沙班进行测量。一项国际研究。
Clin Chem Lab Med. 2016 Feb;54(2):275-83. doi: 10.1515/cclm-2015-0389.
3
Use of specific anti-Xa levels in acute kidney injury to transition patients from oral factor Xa inhibitors to i.v. heparin infusion.在急性肾损伤中使用特定的抗 Xa 水平，将接受口服因子 Xa 抑制剂治疗的患者转换为静脉注射肝素输注。
Am J Health Syst Pharm. 2019 Apr 8;76(8):505-511. doi: 10.1093/ajhp/zxz013.
4
Effects of apixaban on prothrombin time, activated partial thromboplastin time and anti-Xa assays: a European survey.阿哌沙班对凝血酶原时间、活化部分凝血活酶时间及抗Xa活性测定的影响：一项欧洲调查
Clin Chem Lab Med. 2017 Jul 26;55(8):e178-e180. doi: 10.1515/cclm-2016-0742.
5
Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants.即时检测在直接口服抗凝剂治疗患者的紧急凝血评估中的应用。
Crit Care. 2017 Feb 15;21(1):32. doi: 10.1186/s13054-017-1619-z.
6
Transfer of Apixaban into Human Milk.阿哌沙班向人乳中的转移。
Obstet Gynecol. 2021 Jun 1;137(6):1080-1082. doi: 10.1097/AOG.0000000000004388.
7
Laboratory measurement of apixaban using anti-factor Xa assays in acute ischemic stroke patients with non-valvular atrial fibrillation.应用抗因子 Xa 分析法检测急性缺血性脑卒中合并非瓣膜性心房颤动患者的阿哌沙班。
J Thromb Thrombolysis. 2018 Feb;45(2):250-256. doi: 10.1007/s11239-017-1590-1.
8
An Observational Study of the Factor Xa Inhibitors Rivaroxaban and Apixaban as Reported to Eight Poison Centers.八家中毒控制中心报告的抗凝药物因子 Xa 抑制剂利伐沙班和阿哌沙班的观察性研究。
Ann Emerg Med. 2016 Feb;67(2):189-95. doi: 10.1016/j.annemergmed.2015.07.014. Epub 2015 Aug 19.
9
The effect of the direct factor Xa inhibitors apixaban and rivaroxaban on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samples.直接Xa因子抑制剂阿哌沙班和利伐沙班对止血试验的影响：使用体外和体内样本的综合评估
Pathology. 2016 Jan;48(1):60-71. doi: 10.1016/j.pathol.2015.11.025. Epub 2015 Dec 17.
10
Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials.直接Xa因子抑制剂（利伐沙班和阿哌沙班）与依诺肝素用于全膝关节置换术后预防静脉血栓栓塞：6项随机临床试验的荟萃分析
Thromb Res. 2015 May;135(5):816-22. doi: 10.1016/j.thromres.2015.02.008. Epub 2015 Feb 12.

引用本文的文献

1
Rapid assessment of direct oral anticoagulants in acute stroke-An educational systematic review.急性卒中中直接口服抗凝剂的快速评估——一项教育性系统评价
Eur Stroke J. 2025 Apr;10(1_suppl):24-34. doi: 10.1177/23969873241310359. Epub 2025 May 22.
2
A Modified Viscoelastic Point-of-Care Method for Rapid Quantitative Detection of Enoxaparin: A Single-Centre Observational Study.一种用于快速定量检测依诺肝素的改良即时粘弹性护理点方法：一项单中心观察性研究。
J Clin Med. 2025 Feb 17;14(4):1328. doi: 10.3390/jcm14041328.
3
Management of patients with proximal femur fractures under DOACs.
接受直接口服抗凝剂治疗的股骨近端骨折患者的管理
Eur J Trauma Emerg Surg. 2024 Apr;50(2):359-366. doi: 10.1007/s00068-024-02472-4. Epub 2024 Feb 24.
4
The myths behind DOAC measurement: Analyses of prescribing information from different regulatory bodies and a call for harmonization.DOAC 检测背后的误区：来自不同监管机构的说明书分析及实现统一化的呼吁
J Thromb Haemost. 2022 Nov;20(11):2494-2506. doi: 10.1111/jth.15884. Epub 2022 Oct 13.
5
Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxaban.用于接受包括依度沙班在内的直接口服抗凝剂治疗的患者凝血功能紧急评估的即时检验。
Neurol Res Pract. 2021 Mar 1;3(1):9. doi: 10.1186/s42466-021-00105-4.
6
International Normalized Ratio as a Screening Test for Assessment of Anticoagulant Activity for Patients Treated With Rivaroxaban or Apixaban: A Pilot Study.国际标准化比值作为利伐沙班或阿哌沙班治疗患者抗凝活性评估的筛查试验：一项初步研究。
Front Pharmacol. 2019 Oct 8;10:1177. doi: 10.3389/fphar.2019.01177. eCollection 2019.
7
Fully automated thromboelastograph TEG 6s to measure anticoagulant effects of direct oral anticoagulants in healthy male volunteers.使用全自动血栓弹力图仪TEG 6s测量健康男性志愿者中直接口服抗凝剂的抗凝效果。
Res Pract Thromb Haemost. 2019 May 12;3(3):391-396. doi: 10.1002/rth2.12206. eCollection 2019 Jul.
8
Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study.因出血事件入院患者的利伐沙班血浆水平：一项前瞻性研究的见解
Thromb J. 2018 Nov 12;16:28. doi: 10.1186/s12959-018-0183-3. eCollection 2018.